Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia

Overview of attention for article published in Journal of Translational Medicine, July 2022

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (65th percentile)

So far, Altmetric has seen 3 X posts from 2 X users, with an upper bound of 3,379 followers.

Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia #lymphoma #lymsm https://t.co/b1FKZvfVCd

New article: Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia https://t.co/ZfcVC8Vesq #DLBCL #lymsm #hematology https://t.co/uzhE140lLo

New article: Homoharringtonine is synergistically lethal with BCL-2 inhibitor APG-2575 in acute myeloid leukemia https://t.co/eWFm0zD36Q #AML #leusm #hematology https://t.co/HeX9UFAwoz

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.